Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia in gray bats is most common and severe during lactation, likely due to stress and nutrition.

Testosterone increases hair testosterone levels, stress raises hair cortisol, and relationship status affects hormone levels.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

PRP is an effective and safe treatment for alopecia areata.

Finasteride in male rats causes liver and metabolic issues in their offspring.

New genetic locations explain much of hair color variation in Europeans.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Weight loss improves PCOS symptoms and overall health.

A new technology showed that the SOX9 gene might control heart scar formation after injury, suggesting new treatment possibilities.

A group has developed therapies that show promise for treating cancer and various other conditions.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The document concludes that a deeper understanding of skin aging and photodamage is needed to create better skin treatments.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Aging in men is influenced by genetics and lifestyle, leading to muscle loss, bone issues, and skin damage.

Finasteride helps reduce heart enlargement in heart failure patients.